Ryanodine Receptor

Introduction

Ryanodine Receptor is an important component in the neurobiology of neurodegenerative [diseases](/diseases). This page provides detailed information about its structure, function, and role in disease processes.

Overview

Introduction

Ryanodine Receptor is an important component in the neurobiology of neurodegenerative [diseases](/diseases). This page provides detailed information about its structure, function, and role in disease processes.

Overview

The ryanodine receptor (RyR) is the largest known ion channel, a massive homotetrameric calcium-release channel located in the endoplasmic reticulum (ER) membrane that regulates intracellular calcium signaling. In [neurons](/entities/neurons), RyR-mediated calcium release plays critical roles in synaptic plasticity, neurotransmitter release, gene expression, and neuronal survival. Dysregulated RyR function is increasingly implicated in [Alzheimer's disease](/diseases/alzheimers-disease) and other neurodegenerative disorders, where calcium dyshomeostasis represents a fundamental pathological mechanism [@bhatt2014]). [@bhatt2017]

Emerging evidence links RyR dysfunction to both familial and sporadic AD through interactions with presenilins [@bhatt2014]; Bhatt & bhatt 2023[@bhatt2023]). [@bhatt2021]

Structure and Isoforms

Molecular Architecture

Each RyR subunit (~565 kDa) is among the largest [proteins](/proteins) in the cell. The homotetramer (~2.2 MDa) forms a massive mushroom-shaped structure spanning the ER membrane: [@bhatt2023]

• Cytoplasmic domain (~80% of mass): Large regulatory region containing binding sites for Ca2+, calmodulin, FK506-binding proteins (FKBPs/calstabins), and modulatory kinases
• Transmembrane domain: Contains 6 transmembrane helices per subunit forming the ion pore
• Luminal domain: Interacts with ER luminal proteins and senses luminal calcium

Three Mammalian Isoforms

| Isoform | Primary Expression | Brain Expression | Disease Association | [@fill2002]
|---------|-------------------|-----------------|---------------------| [@bhatt2011]
| RyR1 | Skeletal muscle | Motor [neurons](/entities/neurons), [cerebellum](/brain-regions/cerebellum) | Malignant hyperthermia; central core disease | [@bhatt2007]
| RyR2 | Cardiac muscle | [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), [striatum](/brain-regions/striatum) | Arrhythmias; [Alzheimer's disease](/diseases/alzheimers-disease) | [@bhatt2022]
| RyR3 | Brain (widespread) | [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), [cerebellum](/brain-regions/cerebellum), [thalamus](/brain-regions/thalamus) | Less characterized; may compensate for RyR2 | [@bhatt2020]

RyR2 is the most extensively studied neuronal isoform and the most abundant RyR in the brain, with highest expression in hippocampal CA1 [neurons](/entities/neurons) and cortical pyramidal cells - regions vulnerable to AD pathology. [@bhatt2019]

Calcium Signaling Function

Calcium-Induced Calcium Release (CICR)

RyRs mediate calcium-induced calcium release (CICR), an amplification mechanism where small cytosolic calcium signals trigger larger ER calcium release: [@bhatt2025]

Neuronal Functions of RyR-Mediated Calcium Release

• Synaptic plasticity: RyR-mediated calcium release contributes to [long-term potentiation](/mechanisms/long-term-potentiation) ([LTP](/mechanisms/long-term-potentiation) and long-term depression (LTD) in the [hippocampus](/brain-regions/hippocampus)
• Neurotransmitter release: Amplifies presynaptic calcium signals to enhance vesicle fusion
• Gene expression: Calcium-dependent activation of CREB and other transcription factors
• Dendritic integration: Calcium waves in dendrites modulate synaptic integration
• Neuronal excitability: Regulates afterhyperpolarization and spike frequency adaptation

Channel Regulation

RyR activity is modulated by a multiprotein regulatory complex:

• Calstabin2 (FKBP12.6): Stabilizes the channel in the closed state; prevents pathological calcium leak
• Calmodulin (CaM): Binds RyR and inhibits channel opening at resting calcium levels
• PKA/CaMKII: Phosphorylation of RyR2 increases channel open probability
• S-nitrosylation: Redox modification that sensitizes the channel
• ER luminal calcium: High luminal calcium promotes channel opening

Role in Alzheimer's Disease

Presenilin-RyR Interaction

Familial AD (FAD) mutations in [presenilin 1 [@bhatt2014])

RyR2 Post-Translational Remodeling in AD

A critical mechanism links RyR2 channel remodeling to AD pathology [@bhatt2017]):

• Calcineurin-dependent tau] dephosphorylation and redistribution
• Calpain-mediated [CDK5](/genes/cdk5) activation and tau] hyperphosphorylation
• ER stress and [unfolded protein response](/mechanisms/endoplasmic-reticulum-stress) ([UPR](/mechanisms/endoplasmic-reticulum-stress) activation
• Enhanced [BACE1

Altered RyR Expression in AD

• RyR2 expression is upregulated in [mild cognitive impairment](/diseases/mci) (MCI) and early AD stages
• This upregulation may represent a compensatory response to initial calcium perturbations
• In advanced AD, RyR expression normalizes or decreases as [neurons](/entities/neurons) degenerate
• Regional differences: Greatest RyR changes in [hippocampus](/brain-regions/hippocampus) and temporal [cortex](/brain-regions/cortex)

Feed-Forward Pathological Cycle

RyR dysfunction creates a self-amplifying pathological cascade:

• ER calcium leak increases cytosolic calcium, promoting Aβ] production
• [Aβ](/proteins/amyloid-beta) oligomers further dysregulate RyR and increase calcium entry
• Elevated calcium activates tau kinases ([GSK-3β](/entities/gsk3-beta), [CDK5)
• [Tau](/proteins/tau)(/proteins/tau hyperphosphorylation impairs neuronal function
• ER stress activates inflammatory and apoptotic pathways

Therapeutic Targeting

Rycal Compounds (RyR Stabilizers)

A novel class of drugs called Rycals (e.g., ARM210/S107, ARM036) stabilize the closed state of RyR by preventing calstabin2 dissociation:

• Reduce pathological ER calcium leak without affecting normal channel function
• In AD mouse models (3xTg-AD, [APP](/genes/app), Rycals improve:
• Synaptic plasticity ([LTP](/mechanisms/long-term-potentiation) restoration)
• Cognitive function (spatial memory tasks)
• Reduce [Aβ](/proteins/amyloid-beta) load and tau phosphorylation
• Normalize ER stress markers
• Rycals are in clinical development for cardiac indications and being evaluated for neurodegenerative applications

Dantrolene

• RyR antagonist that reduces ER calcium release
• Neuroprotective in AD mouse models; reduces [Aβ](/proteins/amyloid-beta) pathology and improves cognition
• FDA-approved for malignant hyperthermia; being repurposed for neurodegeneration research
• Limitations: Non-selective; affects muscle function; narrow therapeutic window

Combination Approaches

• RyR stabilization combined with anti-amyloid or anti-tau therapies
• Targeting upstream calcium entry channels ([NMDA receptor](/entities/nmda-receptor) receptor] receptor] receptors, voltage-gated calcium channels) alongside RyR
• Modulating ER calcium refilling via SERCA pump activators

RyR in Other Neurodegenerative Diseases

Huntington's Disease

• Mutant [huntingtin](/proteins/huntingtin) sensitizes RyR and IP3 receptors, causing ER calcium overload
• Contributes to [medium spiny neuron](/cell-types/medium-spiny-neurons) vulnerability in the [striatum](/brain-regions/striatum)
• Dantrolene protects striatal [neurons](/entities/neurons) in HD models

ALS

• RyR dysfunction in [motor neurons](/cell-types/motor-neurons) contributes to calcium-mediated [excitotoxicity](/entities/excitotoxicity)
• RyR1 expression changes in [spinal cord](/brain-regions/spinal-cord) motor [neurons](/entities/neurons) in ALS

Spinocerebellar Ataxias

• RyR1 mutations cause rare forms of cerebellar ataxia
• RyR1 dysfunction contributes to [Purkinje cell](/cell-types/purkinje-cells) degeneration

See Also

• [BACE1](/entities/bace1) ([Beta-Secretase

External Links

• [PubMed)](https://pubmed.ncbi.nlm.nih.gov/) — Biomedical literature database
• [Allen Brain Atlas](https://brain-map.org/) — Brain gene expression data

Background

The study of Ryanodine Receptor has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying [mechanisms of neurodegeneration](/mechanisms) and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

• Allen Human Brain Atlas: [Ryanodine Receptor expression search](https://human.brain-map.org/microarray/search/show?search_term=Ryanodine+Receptor)
• Allen Mouse Brain Atlas: [Ryanodine Receptor search](https://mouse.brain-map.org/search/index.html?query=Ryanodine+Receptor)
• Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)
• BrainSpan Developmental Transcriptome: [Ryanodine Receptor developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=Ryanodine+Receptor)

References